This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
New technologies, shifting regulations, and a heightened focus on biotechnology and pharmaceuticals meant that professionals needed to stay ahead of the curve. I saw a gap in the market—a demand for comprehensive, high-quality training that could empower individuals and drive progress in the industry.
Rapid advancements in biotechnology and personalized medicine have increased the demand for specialized expertise, outpacing the supply. Navigating Talent Acquisition Complexities in Life Sciences Securing top talent in life sciences is challenging due to a scarcity of qualified professionals and intense competition.
Genentech is a global biotechnology company that created an entire drug discovery industry. To realize their ambitious vision, they recruit superstar scientists who study complicated human DNA, decode genetic puzzles, and create antibodies to treat life-threatening diseases like cancer and multiple sclerosis.
Given that the global biotechnology market was valued at USD 1.55 If sophisticated investors are involved — as often happens in biotech — the plan is undoubtedly subjected to intensive due diligence. Models are developed, scrutinized, and refined. All of this hard work usually involves smart people with significant experience.
The government of India has also launched several funding […] The post Biotechnology frontiers- Research and funding opportunities, Are CEOs ready? India too has extended opportunities for researchers engaged in the field of life sciences, intending to capitalise international funding schemes for mutual gain.
Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. And yet the U.S. ranks 30 out of 38 nations in terms of work/life balance, according to a recent study by Family Living Today and NowSourcing.
Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. And yet the U.S. ranks 30 out of 38 nations in terms of work/life balance, according to a recent study by Family Living Today and NowSourcing.
Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. And yet the U.S. ranks 30 out of 38 nations in terms of work/life balance, according to a recent study by Family Living Today and NowSourcing.
While companies and universities have long worked together, this partnership is becoming even more crucial in industries like biotechnology, which are facing challenges due to fluctuating interest rates affecting venture capital and mergers.
For example, a multi-billion-dollar biotechnology company recently contacted me for a training on executive presence to help newly minted high-potential mid-level managers reach the next level of leadership. Here’s the program and what the audience learned.
A solid grasp of the latest advancements across biotechnology, pharmaceuticals, and medical devices is essential in driving innovations and the ability to synthesize information and translate it into actionable strategies quickly. This ability to bridge the gap between science and strategy is crucial in such a highly dynamic space.
He has spent most of his professional life as a private research consultant, working primarily in the biotechnology and pharmaceutical industries on research related to mental health. John Medina is a developmental molecular biologist focused on the genes involved in human brain development and the genetics of psychiatric disorders.
In virtually every advanced field, whether it be information technology, biotechnology, agriculture or renewable energy, America holds a leading position. Since World War II, the United States has been an innovation superpower. Other nations may challenge in one field or another, but no one can match its depth and breadth.
Two other technologies advanced sensors and biotechnology are less visible, though no less important, and have been quietly advancing. This is the new reality of living intelligence: systems that can sense, learn, adapt, and evolve, made possible through artificial intelligence, advanced sensors and biotechnology.
The dynamics of these relationships are, the researchers believe, likely to be common in other similar partnerships, such as between a biotechnology firm and a pharmaceutical partner. Often this dynamic seems to prompt publishers to prefer working with these more experienced partners.
Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. And yet the U.S. ranks 30 out of 38 nations in terms of work/life balance, according to a recent study by Family Living Today and NowSourcing.
Guest post from Amy Blankson: In 2013, the National Center for Biotechnology Information reported that the average attention span of a human has dropped to a mere eight seconds , one second behind that of a goldfish. Why does this matter?
Moderna, a prominent pharmaceutical and biotechnology firm, adopted an unconventional approach utilizing RNA technology to develop one of the COVID-19 vaccines. Their advisory board consists of individuals with educational backgrounds in fields such as medical sciences, economics, journalism, and finance.
Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas.
Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. And yet the U.S. ranks 30 out of 38 nations in terms of work/life balance, according to a recent study by Family Living Today and NowSourcing.
There are some other categories not listed here which are showing remarkable growth, including life sciences and biotechnology and research. Expectedly, the highest growth opportunities will be centered around caretakers, health aides and caregivers.
There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. This increased the need for care items for the elderly and there are plenty of gaps in the market for the healthcare sector.
While Silicon Valley is best known for their technology companies – Google, Yahoo, Apple, Hewlett Packard, Intel, and Facebook to name a few, the Bay Area is also home to some of the most cutting edge biotechnology and medical device companies. The job at a small biotechnology company was a great match for his skills.
The first leader was someone I worked with as part of the management team at a biotechnology firm, and how he guided our organization during the merger of our North American parent company with a much larger European multinational.
If it is a venture capital-oriented IT, hardware or biotechnology company, this destination might be Silicon Valley.”. “A company should move to where the best resources are located, as long as the benefit covers the cost of moving,” the authors say. “If
The biotechnology company announced Gomez’s appointment as the new Moderna CFO on April 11. Moderna CFO Jorge Gomez had assumed the position just one day prior, almost a month after leaving a dental company. While Moderna looks for a replacement, his recently retired predecessor, David Meline, will continue to work as the CFO.
I heard a cautionary tale from “George” the former VP of marketing at a mid-sized biotechnology company about how a bogus forecast helped propagate a disaster. It is tempting to think that these numbers are scientifically derived and reliable, but often they come from sticking a finger in the air, and then justified after-the-fact in Excel.
Prior to launching her wellness practice, she worked in the management consulting industry and at one of the leading cancer research biotechnology companies. Catherine Chen, Ph.D., is a Health Coach who supports high-octane professionals to achieve with ease, have time for what they love, and live a balanced life.
Drug Research —The applications for drug design and biotechnology using 3D displays can be exponential. With 3D tomosynthesis, doctors can pinpoint the size and location of cancer tumors in dense tissue; they can detect abnormalities earlier and better see small tumors because the images are clearer and have greater contrast.
Further supporting this, a study published in the National Center for Biotechnology Information (NCBI) emphasizes executive coaching as an effective developmental tool for managers. This research highlights the positive effects of coaching on behaviors, attitudes, and overall performance.
GUEST POST from Greg Satell Many experts suspect that the COVID crisis is receding into the background. It is, of course, hard to know for sure. There will continue to be debate and we will still need to have some mitigating measures in place. Still, for the most part, people are back at work, kids […]
Unfortunately, many of us have developed expertise in only one field (software engineering, information technology [IT], marketing, biotechnology, automobile manufacturing, the food industry, etc. The more knowledge you possess in more areas, the more problems you can solve in pursuit of your vision. and we like to stick to our knitting.
For example, if you are a biotechnology fund manager who wants to communicate the importance of investing in biotechnology, you may think that your value is in your recent success in investing for shareholders, but if you are a reasonable person, you will likely also have doubts about this.
There are intriguing signs that we might be approaching the point where digital innovation takes a big leap into the physical world: 3D printers are breaking into the mainstream , tech billionaires are backing an asteroid mining venture , and lots of people keep saying that biotechnology is the next great frontier.
Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive.
For the past few decades, emerging technologies such as biotechnology, microelectronics, information technology and communications technologies have become central to the socioeconomic development of nations. These technologies improve productivity and facilitate better living standards when they penetrate into societies.
That was the question Todd Pierce asked himself in 2006 after years of experimenting with the full menu of trainings, meetings, and competency models in his capacity as CIO of biotechnology giant Genentech. I remember sitting there and saying, 'There's got to be a another way.'".
Another CEO of a fast-growing biotechnology venture, a Chinese-American entrepreneur, added that he wanted his company to be perceived as American rather than as Chinese. "Most technology ventures in China are of the C2C variety, i.e., Copy-To-China.
The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. China and India, in particular, offer attractive liquidity and investment opportunities VCs haven't seen for a while.
And biotechnology and medical devices are among the leading areas for venture capital funding. Virtually every day, there is information about a clinical study with a new way to treat sick people. Fortunes have been made from implants, surgical instruments, and artificial products.
Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa? Wouldn't it make sense to test drive state-owned banks elsewhere to see if they could help support local industries? Our 50 states have been called laboratories of democracy.
French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology. Nestle, Unilever, and Novartis have several business units based in the U.S. America fosters risk-taking and innovation by entrepreneurs who become global leaders.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content